This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Pooh-Poohing Private Equity

Go Soros One Better

"Everyone wants to invest like George Soros," Cramer told his viewers. At least, that's what he gathers from the fact that the George Soros portfolio is stockpickr.com's most popular.

But Cramer said he doesn't want to invest like Soros. "I want to be better than Soros!" he said.

For example, Soros owns Bon-Ton (BONT), but Cramer wouldn't, because it's "too dicey. ... Maybe it's a long-term Soros pick, because short term it really stinks."

Soros also owns CVS (CVS), which Cramer said he likes after its great Caremark deal, "but I have preferred over and over again Rite Aid (RAD)."

And Soros own Qualcomm (QCOM), but Cramer prefers Texas Instruments (TXN).

The one Soros stock that Cramer said he really thinks people should be in is diagnostics company Gen-Probe (GPRO).

"On 'Mad Money,'" he said, "we're delighted by diagnostics." He owns two diagnostics companies -- Inverness Medical Innovations (IMA) and Hologic (HOLX) -- for his charitable trust, Action Alerts PLUS .

As for Gen-Probe, Cramer said it is "instant growth."

It is one of the two major providers of blood-screening tests, with 40% of market share. It also is in an "enviable position with 58% of the market for chlamydia and gonorrhea tests."

In addition, the company has its future all worked out, with alliances with General Electric (GE), 3M (MMM) and Millipore (MIL).

"Don't invest like George Soros," Cramer said. "Invest better than George Soros. Go buy some Gen-Probe."

Mad Mail

In his "Mad Mail" segment, Cramer agreed with one viewer that Manitowoc (MTW) is "absolutely" a stock that should be considered for Cramer's $80-to-$120 theory.

4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs